FILE PHOTO: A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai | Photo: Reuters
Sun Pharma: Strong Q1 show, settlement of antitrust case pleases investors
EVs to account for 25% of Tata Motors' PV sales: N Chandrasekaran
A strong Q1, 2021-22 (Apr-Jun 2021) performance saw the share price of Sun Pharma
jump by 10 per cent in a single session. The pharma major had terrific year-on-year (YoY) results, boosted by the low base of Q1, 2020-21. But it also had a pretty good quarter-on-quarter (QoQ) performance versus Jan-Mar 2021 (Q4, 2020-21).
The consolidated results saw operational revenues climbing to Rs 9,719 crore versus Rs 7,585 crore YoY and versus Rs 8,522 crore QoQ. Sales grew by double-digits YoY in all of its major markets. Read more
Indian billionaire Rakesh Jhunjhunwala's plan to launch an ultra low-cost airline could give planemaker Boeing a chance to regain lost ground in India after the fall of one of its biggest customers, Jet Airways, two years ago, industry executives say.
Jhunjhunwala, known as India's Warren Buffett for his successful stock investments, plans to team up with former CEOs of IndiGo, the country's biggest carrier, and Jet Airways to tap into demand for domestic air travel. Read more
India, China to hold 12th round of military-level talks on Saturday
India and China will hold the 12th round of Corps Commander-level talks at Moldo on the Chinese side of the Line of Actual Control (LAC) on Saturday to iron out an agreement for the next phase of disengagement in Eastern Ladakh.
The latest round of talks will take place after a gap of three months. Indian military delegates will meet their counterparts to discuss disengagement of troops at the friction areas such as the Hot Springs, Gogra and the Depsang plains spread over 900 sq km land. Read more
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.